In the case of CDC25B, it has been thought that as a regulator of the G2-M transition, this phosphatase did not act at the G1-S transition and in S-phase, and that the oncogenic properties associated with its overexpression in tumours could be related to G2-M checkpoint bypass and unscheduled entry into mitosis. This evidence concerns the gene CDC25B and neoplasm.